Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
about
Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvementCardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes.Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes.Food protein-derived bioactive peptides in management of type 2 diabetes.Flavanol concentrations do not predict dipeptidyl peptidase-IV inhibitory activities of four cocoas with different processing histories.Modulation of Adipocytokines Production and Serum NEFA Level by Metformin, Glimepiride, and Sitagliptin in HFD/STZ Diabetic Rats.Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats.
P2860
Q27003819-3898A40A-1ABB-4413-BF9F-F028338BD5E7Q38068353-06D6E41C-1A12-4E8E-B42E-5AC215C8D6DDQ38128788-DF4E4B46-C9D0-4964-937A-E8FCBC8B0596Q38180221-09DF1B4F-7DE2-486D-A107-8487FFF635E4Q38543982-B1B71FAB-51EC-4DD9-BE88-53966B87E175Q39010537-4E92C77B-B7C6-421B-A82A-FAB4D68C55BAQ43198025-F8E0105A-D879-4FDF-BAF1-10BCD3CF3C5CQ43218274-20CE1A71-4C90-41CE-BD6A-C04397685C05
P2860
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@ast
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@en
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@nl
type
label
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@ast
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@en
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@nl
prefLabel
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@ast
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@en
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@nl
P2860
P1476
Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies
@en
P2093
Daniel Addison
David Aguilar
P2860
P2888
P304
P356
10.1007/S11883-010-0153-0
P577
2011-04-01T00:00:00Z
P5875
P6179
1026689616